Brainstorm Cell Therapeutics | BCLI - Net Income


Brainstorm Cell Therapeutics reported $-2.13M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Biogen USD 97.5M 222M Jun/2026
Brainstorm Cell Therapeutics USD -2.13M 21K Mar/2026
Cipla INR 7.89B 2.34B Jun/2026
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD -7.67M 64.51M Mar/2026
CSL USD 401M 96.5M Dec/2025
Cytokinetics USD -198.76M 7.27M Jun/2026
Gilead Sciences USD -10.5B 12.52B Jun/2026
Grifols EUR 114.37M 34.03M Dec/2025
Halozyme Therapeutics USD 229.91M 79.86M Jun/2026
Mesoblast USD -40.16M 14.05M Dec/2025